Imprinting fidelity in mouse iPSCs depends on sex of donor cell and medium formulation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 09 2022
Historique:
received: 05 11 2020
accepted: 29 08 2022
entrez: 16 9 2022
pubmed: 17 9 2022
medline: 21 9 2022
Statut: epublish

Résumé

Reprogramming of somatic cells into induced Pluripotent Stem Cells (iPSCs) is a major leap towards personalised approaches to disease modelling and cell-replacement therapies. However, we still lack the ability to fully control the epigenetic status of iPSCs, which is a major hurdle for their downstream applications. Epigenetic fidelity can be tracked by genomic imprinting, a phenomenon dependent on DNA methylation, which is frequently perturbed in iPSCs by yet unknown reasons. To try to understand the causes underlying these defects, we conducted a thorough imprinting analysis using IMPLICON, a high-throughput method measuring DNA methylation levels, in multiple female and male murine iPSC lines generated under different experimental conditions. Our results show that imprinting defects are remarkably common in iPSCs, but their nature depends on the sex of donor cells and their response to culture conditions. Imprints in female iPSCs resist the initial genome-wide DNA demethylation wave during reprogramming, but ultimately cells accumulate hypomethylation defects irrespective of culture medium formulations. In contrast, imprinting defects on male iPSCs depends on the experimental conditions and arise during reprogramming, being mitigated by the addition of vitamin C (VitC). Our findings are fundamental to further optimise reprogramming strategies and generate iPSCs with a stable epigenome.

Identifiants

pubmed: 36114205
doi: 10.1038/s41467-022-33013-5
pii: 10.1038/s41467-022-33013-5
pmc: PMC9481624
doi:

Substances chimiques

Ascorbic Acid PQ6CK8PD0R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5432

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/T009713/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/B/000C0421
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Mol Cell. 2014 Jan 23;53(2):301-16
pubmed: 24462204
Stem Cell Reports. 2019 Feb 12;12(2):333-350
pubmed: 30639215
Mol Cell. 2016 Jun 16;62(6):848-861
pubmed: 27237052
Cell Stem Cell. 2016 Sep 1;19(3):341-54
pubmed: 27476965
Cell Stem Cell. 2015 May 7;16(5):533-46
pubmed: 25921272
Cell Stem Cell. 2019 Oct 3;25(4):456-461
pubmed: 31543368
Genet Med. 2012 Jan;14(1):10-26
pubmed: 22237428
Genes Dev. 2011 Jul 1;25(13):1371-83
pubmed: 21690198
Nature. 2011 Mar 3;471(7336):63-7
pubmed: 21368825
Cell Mol Life Sci. 2008 Nov;65(21):3383-98
pubmed: 18818872
Stem Cell Res. 2013 Sep;11(2):861-73
pubmed: 23832110
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16196-201
pubmed: 22991473
Cell. 2019 Feb 21;176(5):952-965
pubmed: 30794780
Stem Cell Reports. 2018 May 8;10(5):1537-1550
pubmed: 29681539
Genome Biol. 2015 May 30;16:112
pubmed: 26025256
Nature. 2013 Aug 8;500(7461):222-6
pubmed: 23812591
Cell Stem Cell. 2012 May 4;10(5):620-34
pubmed: 22560082
Cell Stem Cell. 2019 Dec 5;25(6):737-753.e4
pubmed: 31708402
Cell. 2012 Feb 17;148(4):816-31
pubmed: 22341451
Nat Cell Biol. 2011 May;13(5):541-9
pubmed: 21499256
Cell Stem Cell. 2011 Dec 2;9(6):588-98
pubmed: 22136932
Nucleic Acids Res. 2020 Sep 18;48(16):e92
pubmed: 32621604
Nature. 2014 Jul 10;511(7508):177-83
pubmed: 25008523
J Biol Chem. 2010 Jun 18;285(25):19483-90
pubmed: 20382743
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Nat Rev Immunol. 2007 Feb;7(2):118-30
pubmed: 17259968
Nature. 2010 May 13;465(7295):175-81
pubmed: 20418860
Cell Stem Cell. 2014 Feb 6;14(2):203-16
pubmed: 24506884
Development. 2002 Apr;129(8):1983-93
pubmed: 11934864
Stem Cell Res Ther. 2015 Jan 05;6:1
pubmed: 25559585
Nature. 2015 Sep 24;525(7570):469-78
pubmed: 26399828
Cell Rep. 2017 Jan 31;18(5):1079-1089
pubmed: 28147265
Nature. 2009 Jul 2;460(7251):49-52
pubmed: 19571877
Hum Mutat. 2007 Jun;28(6):527-39
pubmed: 17309057
Cell Rep. 2017 May 2;19(5):957-968
pubmed: 28467909
Nat Commun. 2018 Jan 8;9(1):94
pubmed: 29311544
Nat Struct Mol Biol. 2013 Mar;20(3):311-6
pubmed: 23416945
Elife. 2016 Jan 27;5:
pubmed: 26814573
Curr Protoc Mol Biol. 2005 May;Chapter 28:Unit 28.1
pubmed: 18265366
Cell Stem Cell. 2013 Sep 5;13(3):360-9
pubmed: 23850244
Front Pediatr. 2020 Jan 21;7:562
pubmed: 32039119
Cell. 2019 Feb 7;176(4):928-943.e22
pubmed: 30712874
Nat Cell Biol. 2011 Jan;13(1):66-71
pubmed: 21131959
Nat Commun. 2021 Jun 9;12(1):3499
pubmed: 34108480
Clin Genet. 2017 Jan;91(1):3-13
pubmed: 27363536
FEBS J. 2020 Jun;287(11):2154-2175
pubmed: 32087041
Stem Cells. 2012 Feb;30(2):161-8
pubmed: 22109880
Nat Rev Genet. 2019 Apr;20(4):235-248
pubmed: 30647469
Nat Methods. 2009 Jul;6(7):493-5
pubmed: 19525957
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12538-43
pubmed: 22802639
Nat Rev Drug Discov. 2017 Feb;16(2):115-130
pubmed: 27980341
Genes Cells. 2018 Mar;23(3):146-160
pubmed: 29356242
Nature. 2014 Dec 11;516(7530):192-7
pubmed: 25503232
Genome Res. 2019 Oct;29(10):1659-1672
pubmed: 31515287
Nat Commun. 2014 Sep 08;5:4825
pubmed: 25198699
Cell Stem Cell. 2010 Sep 3;7(3):329-42
pubmed: 20727844
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cell Rep. 2020 Mar 17;30(11):3597-3604.e3
pubmed: 32187532
Nature. 2017 Aug 10;548(7666):219-223
pubmed: 28746311
Cell Stem Cell. 2013 Sep 5;13(3):351-9
pubmed: 23850245
Stem Cell Reports. 2017 Jan 10;8(1):69-83
pubmed: 28076757
Cell. 2011 Feb 4;144(3):439-52
pubmed: 21295703
Cell Stem Cell. 2017 May 4;20(5):706-719.e7
pubmed: 28366588
Nature. 2011 Mar 3;471(7336):68-73
pubmed: 21289626
Stem Cell Reports. 2019 Oct 8;13(4):761-774
pubmed: 31564644
Cell Stem Cell. 2011 Jul 8;9(1):17-23
pubmed: 21726830
PLoS Biol. 2005 Sep;3(9):e283
pubmed: 16086633
Nat Biotechnol. 2011 Nov 27;29(12):1117-9
pubmed: 22119740
Stem Cell Reports. 2019 May 14;12(5):1113-1128
pubmed: 31056481
Nat Genet. 2005 Nov;37(11):1274-9
pubmed: 16244654
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20569-74
pubmed: 24259714
Stem Cell Reports. 2013 Dec 26;2(1):36-43
pubmed: 24511466
Nat Rev Genet. 2013 Jun;14(6):427-39
pubmed: 23681063
Nature. 2013 Oct 17;502(7471):340-5
pubmed: 24025773
Nat Genet. 2012 Mar 04;44(4):398-405, S1-2
pubmed: 22387999
Nat Biotechnol. 2010 Aug;28(8):848-55
pubmed: 20644536
Cell Stem Cell. 2012 May 4;10(5):595-609
pubmed: 22560080

Auteurs

Maria Arez (M)

iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Associate Laboratory i4HB Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Melanie Eckersley-Maslin (M)

Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT, United Kingdom.
Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, 3010, Australia.
Department of Anatomy and Physiology, The University of Melbourne, Victoria, 3010, Australia.

Tajda Klobučar (T)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
National Institute of Chemistry, Ljubljana, Slovenia.

João von Gilsa Lopes (J)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
NOVA Medical School|Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, Lisboa, Portugal.

Felix Krueger (F)

Bioinformatics Group, Babraham Institute, Cambridge, CB22 3AT, United Kingdom.
Altos Labs, Cambridge, United Kingdom.

Annalisa Mupo (A)

Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT, United Kingdom.
Altos Labs, Cambridge, United Kingdom.

Ana Cláudia Raposo (AC)

iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Associate Laboratory i4HB Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

David Oxley (D)

Mass Spectrometry Facility, The Babraham Institute, Cambridge, United Kingdom.

Samantha Mancino (S)

iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Associate Laboratory i4HB Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Anne-Valerie Gendrel (AV)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Genetics and Developmental Biology Unit, Institut Curie, INSERM U934, CNRS UMR3215, PSL University, Paris, France.

Bruno Bernardes de Jesus (B)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Department of Medical Sciences and Institute of Biomedicine - iBiMED, University of Aveiro, 3810-193, Aveiro, Portugal.

Simão Teixeira da Rocha (ST)

iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal. simao.rocha@tecnico.ulisboa.pt.
Associate Laboratory i4HB Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal. simao.rocha@tecnico.ulisboa.pt.
Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. simao.rocha@tecnico.ulisboa.pt.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH